Kamari Pharma
Small Molecule Inhibitors of TRPV3
Active
A
Startup
Ness Ziona
Founded 2018-10
Kamari Pharma is a biopharmaceutical company aiming to develop and commercialize proprietary small molecule inhibitors of TRPV3, a cation channel expressed primary in keratinocytes, for the treatment of dermatological conditions with unmet need. TRPV3 has been extensively evaluated as a target for drug development, identified as the cause of Olmsted syndrom…
SectorHealth Tech & Life Sciences
StageA
Total raised$31.0M
Employees9
Founded2018-10
HQNess Ziona
Patents1
Confidence89
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals